Target intelligence / Profile preview

RNA binding motif protein 20 (RBM20)

Target
RBM20
Molecular classification
Splicing factor, RNA-binding protein, Serine-arginine-rich (SR) protein family, Contains RNA Recognition Motif (RRM) domain, Contains zinc finger domains (ZnF)
01

Overview

RNA binding motif protein 20 (RBM20) is a large, muscle-specific and vertebrate splicing factor encoded by the *RBM20* gene on chromosome 10 (human). The protein is 1227 amino acids long and features several key domains: an N-terminal RNA Recognition Motif (RRM), two U1-type zinc finger domains, a large serine-arginine-rich (RS) domain, and regions rich in proline, leucine, and glutamate. RBM20 acts primarily as an alternative splicing repressor, regulating cardiac-specific isoforms of muscle proteins—most notably titin—critical for heart development and function. Mutations in *RBM20* are strongly linked to dilated and hypertrophic cardiomyopathies, with pathogenic variants often causing mislocalization and destabilization of the protein and subsequent splicing defects. RBM20 also has defined roles in neuronal RNA metabolism, binding and regulating long intronic transcripts in specific neural cell types. Approaches to modulate RBM20 activity or function are of therapeutic interest, but no approved drugs directly target RBM20. Challenges include tissue specificity, broad impact on alternative splicing, and risk of unintended effects in both heart and neural cells[2][3][1].

Other names
RNA-binding motif protein 20RNA-binding protein 20Probable RNA-binding protein 20RBM20
02

Mechanism of action

Modulation of RNA splicing via direct or indirect targeting of RBM20 activity; Correcting RBM20 missplicing or mislocalization to restore normal transcript isoforms of cardiac proteins (titin, CAMK2D)

03

Biological functions

Regulation of alternative splicing of pre-mRNARepression of exon inclusion (mainly acts as a splicing repressor in the heart)Promotes formation of nuclear "splicing factories" (in cardiomyocytes)Regulation of mRNA stability (especially titin and other muscle-related genes)Regulation of neuronal gene expression and synapse-related mRNA metabolism
04

Disease associations

Cardiovascular disease – especially dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), sudden death, left ventricular noncompaction cardiomyopathy (LVNC)Possible roles in neurodegenerative diseases (expression/function in neural tissue)
05

Safety considerations

Therapeutic challenge: RBM20 has essential roles in cardiac and neural tissues.Risk of off-target effects altering alternative splicing of multiple transcripts, leading to unpredictable systemic effects.Genetic variants may destabilize the protein and promote disease (esp. cardiomyopathy).Nuclear mislocalization can cause loss of function and developmental issues.
06

Interacting drugs

None with direct established clinical interaction; most research is preclinical, focusing on gene editing, molecular modulation, or antisense strategies. No approved drugs specifically targeting RBM20 were identified in the search results.
07

Biomarkers

RBM20 levels and localization in cardiac tissueSplicing patterns of specific mRNAs: titin (*TTN*), CAMK2D, others – used as indicators of RBM20 function/disruption

Beyond the preview

Go deeper on RNA binding motif protein 20 (RBM20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA binding motif protein 20 (RBM20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call